We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TMBSZ market cap is 285.43k. The company's latest EPS is EUR -3.9761 and P/E is -0.06.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 378k | 279k | 147k | 82k | 34k |
| Operating Income | -4.32M | -3.94M | -5.75M | -13.45M | -12M |
| Net Income | -10.73M | -861k | -10.41M | -14.45M | -15.13M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 4.52M | 1.73M | 10.65M | 9.77M | 5.24M |
| Total Liabilities | 7.13M | 3.59M | 2.96M | 5.27M | 6.51M |
| Total Equity | -2.61M | -1.85M | 7.7M | 4.5M | -1.27M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -4M | -4.29M | -5.22M | -12.38M | -12.14M |
| Investing | 66k | -16k | -39k | -14k | -21k |
| Financing | 7.6M | 1.4M | 14.18M | 11.5M | 7.29M |
| Market Cap | 285.43k |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 26.97 |
| Price to Cash Ratio | 0.2 |
| Price to Book Ratio | -0.72 |
| Dividend Yield | - |
| Shares Outstanding | 3.81M |
| Average Volume (1 week) | 715 |
| Average Volume (1 Month) | 39.03k |
| 52 Week Change | 150.00% |
| 52 Week High | 0.22 |
| 52 Week Low | 0.03 |
| Spread (Intraday) | 0.03 (42.86%) |
| Company Name | TME Pharma NV |
| Address |
max-dohrn-strasse 8-10 berlin 10589 |
| Website | https://www.tmepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
